Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211391.RA1nCOuGGixZqZXFzh9q5wSMNSgr-CONiircef4VymJDU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211391.RA1nCOuGGixZqZXFzh9q5wSMNSgr-CONiircef4VymJDU130_assertion type Assertion NP1211391.RA1nCOuGGixZqZXFzh9q5wSMNSgr-CONiircef4VymJDU130_head.
- NP1211391.RA1nCOuGGixZqZXFzh9q5wSMNSgr-CONiircef4VymJDU130_assertion description "[The efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKI) in patients with non-small cell lung cancer (NSCLC) is related to EGFR mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211391.RA1nCOuGGixZqZXFzh9q5wSMNSgr-CONiircef4VymJDU130_provenance.
- NP1211391.RA1nCOuGGixZqZXFzh9q5wSMNSgr-CONiircef4VymJDU130_assertion evidence source_evidence_literature NP1211391.RA1nCOuGGixZqZXFzh9q5wSMNSgr-CONiircef4VymJDU130_provenance.
- NP1211391.RA1nCOuGGixZqZXFzh9q5wSMNSgr-CONiircef4VymJDU130_assertion SIO_000772 25130612 NP1211391.RA1nCOuGGixZqZXFzh9q5wSMNSgr-CONiircef4VymJDU130_provenance.
- NP1211391.RA1nCOuGGixZqZXFzh9q5wSMNSgr-CONiircef4VymJDU130_assertion wasDerivedFrom befree-2016 NP1211391.RA1nCOuGGixZqZXFzh9q5wSMNSgr-CONiircef4VymJDU130_provenance.
- NP1211391.RA1nCOuGGixZqZXFzh9q5wSMNSgr-CONiircef4VymJDU130_assertion wasGeneratedBy ECO_0000203 NP1211391.RA1nCOuGGixZqZXFzh9q5wSMNSgr-CONiircef4VymJDU130_provenance.